Eimeriavax Plus Vaccine

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

EIMERIA BRUNETTI STRAIN ROYBRU3+28; EIMERIA NECATRIX MEDNEC

Available from:

EIMERIA PTY. LIMITED

Pharmaceutical form:

MISC. VACCINES OR ANTI SERA

Composition:

EIMERIA BRUNETTI STRAIN ROYBRU3+28 VACCINE-GENERAL Active 100.0 ooc/dose; EIMERIA NECATRIX MEDNEC VACCINE-GENERAL Active 50.0 ooc/dose

Units in package:

1000 doses; 5000 doses

Class:

VM - Veterinary Medicine

Therapeutic area:

IMMUNOTHERAPY

Product summary:

Poison schedule: 0; Withholding period: ; Host/pest details: CHICKENS: [COCCIDIOSIS]

Authorization status:

Registered

Authorization date:

2020-07-01

Patient Information leaflet

PRODUCT NAME:
APVMA APPROVAL NO:
EIMERIAVAX PLUS VACCINE
82246/105274
Eimeria necatrix Mednec3+8
≥
100 oocysts/dose
Eimeria brunetti Roybru3+28
≥
50 oocysts/dose
PRECAUTIONS:
Avoid using in-feed or water anticoccidial medications at or soon
after the time of
vaccination, unless controlling clinical coccidiosis.
Avoid vaccinating with Eimeriavax® PLUS unless birds are protected
from exposure to litter
from the previous batch for up to 14 days post-vaccination.
Avoid using Eimeriavax® PLUS as a diluent for other medications or
treatments.
Avoid using in birds in lay.
Avoid administration of sulfa drugs immediately following vaccination
with Eimeriavax®
PLUS as this will delay oocyst output and impair immune response.
CONTRAINDICATIONS:
This product is contraindicated for vaccinating unhealthy birds
RESTRAINTS:
DIRECTIONS FOR USE:
NET CONTENTS:
1000 doses OR 5000 doses
CLAIMS:
Live oocyst preparation to aid in the control of two species of
Eimeria that cause
Coccidiosis in breeder, broiler and layer chickens in Australia. An
effective immune response
can be expected for at least 18 weeks post-vaccination. Continuing
exposure to oocysts in
the environment is essential and provides ongoing stimulus to the
immune system. Under
these conditions, a protective immune response beyond 18 weeks of age
can be expected.
When birds are removed from the source of vaccine oocysts, such as
when they are
transferred between facilities, immunity may wane due to reduced
exposure to cycling
oocysts. As a result, birds may subsequently become susceptible to
field infections from
Eimeria species represented in the vaccine.
CONSTITUENT
STATEMENTS:
SIGNAL HEADINGS:
FOR ANIMAL TREATMENT ONLY
LABEL NAME:
Eimeriavax Plus Vaccine RLP APPROVED
GENERAL DIRECTIONS:
Preparation of vaccine for administration via eyedrop (1000 doses) :
• Eyedrop of the 5000 dose presentation is not recommended due to
the higher
concentration .
• Gently shake bottles to fully resuspend all oocysts and remove the
cap.
• Insert an eye-dropper tip or other